ArticleDrugs in R&D2025

Characterization for the Similarity Assessment Between the Proposed Biosimilar SB17 and Ustekinumab Reference Product Using State-of-the-Art Analytical Methods.

Sung-Yong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.